Market Overview

UPDATE: Deutsche Bank Downgrades Acadia Healthcare to Hold, Reiterates $19 PT

Share:
Related ACHC
5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years
Earnings Scheduled For February 11, 2015
Stocks Hold Solid Gains; Ulta Beauty Rises Ahead Of Earnings (Investor's Business Daily)

In a report published Wednesday, Deutsche Bank downgraded its rating on Acadia Healthcare Company (NASDAQ: ACHC) from Buy to Hold, and reiterated its $19.00 price target.

Deutsche Bank noted, “ACHC's recent run-up puts it within striking distance of our $19 price target. Fundamentally, we believe ACHC is performing in-line with our expectations and we still expect the company's M&A pipeline to turn-up a steady stream of hospital acquisitions (1 per quarter assumed in our model). At current valuations levels (9.1x forward EV/EBITDA), we believe much of the positive sentiment is priced-in and a Hold rating is a more appropriate stance.”

Acadia Healthcare Company closed on Tuesday at $17.90.

Latest Ratings for ACHC

DateFirmActionFromTo
May 2015SusquehannaMaintainsPositive
Apr 2015JefferiesMaintainsBuy
Apr 2015Wells FargoUpgradesMarket PerformOutperform

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Downgrades Analyst Ratings

 

Related Articles (ACHC)

Around the Web, We're Loving...

Get Benzinga's Newsletters